Withaphysalin ACAS# 57423-72-0 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 57423-72-0 | SDF | Download SDF |
| PubChem ID | 180584 | Appearance | Powder |
| Formula | C28H34O6 | M.Wt | 466.6 |
| Type of Compound | Steroids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (1R,2R,5S,6R,12S,13R)-6-[(2R)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-2-hydroxy-6,13-dimethyl-7-oxapentacyclo[10.8.0.02,9.05,9.013,18]icosa-15,18-diene-8,14-dione | ||
| SMILES | CC1=C(C(=O)OC(C1)C2(C3CCC4(C3(CCC5C4CC=C6C5(C(=O)C=CC6)C)C(=O)O2)O)C)C | ||
| Standard InChIKey | XXDCTQHRVNTDTI-OZKLRMFXSA-N | ||
| Standard InChI | InChI=1S/C28H34O6/c1-15-14-22(33-23(30)16(15)2)26(4)20-11-13-28(32)19-9-8-17-6-5-7-21(29)25(17,3)18(19)10-12-27(20,28)24(31)34-26/h5,7-8,18-20,22,32H,6,9-14H2,1-4H3/t18-,19+,20+,22+,25-,26+,27?,28+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
Withaphysalin A Dilution Calculator
Withaphysalin A Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.1432 mL | 10.7158 mL | 21.4316 mL | 42.8633 mL | 53.5791 mL |
| 5 mM | 0.4286 mL | 2.1432 mL | 4.2863 mL | 8.5727 mL | 10.7158 mL |
| 10 mM | 0.2143 mL | 1.0716 mL | 2.1432 mL | 4.2863 mL | 5.3579 mL |
| 50 mM | 0.0429 mL | 0.2143 mL | 0.4286 mL | 0.8573 mL | 1.0716 mL |
| 100 mM | 0.0214 mL | 0.1072 mL | 0.2143 mL | 0.4286 mL | 0.5358 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Withaphysalin E
Catalog No.:BCN9414
CAS No.:118985-24-3
- Withaphysalin S
Catalog No.:BCN9413
CAS No.:949172-13-8
- Methyl (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate
Catalog No.:BCN9412
CAS No.:109837-85-6
- Physaminimin C
Catalog No.:BCN9411
CAS No.:1582259-03-7
- Physaminimin D
Catalog No.:BCN9410
CAS No.:1582259-05-9
- Hyperxanthone
Catalog No.:BCN9409
CAS No.:99481-41-1
- 5-Carboxystrictosidine
Catalog No.:BCN9408
CAS No.:34371-47-6
- 2,7-Dihydroxyxanthone
Catalog No.:BCN9407
CAS No.:64632-72-0
- Mumeose K
Catalog No.:BCN9406
CAS No.:2132384-01-9
- Tyramine hydrochloride
Catalog No.:BCN9405
CAS No.:60-19-5
- Symphonone I
Catalog No.:BCN9404
CAS No.:1235774-18-1
- Platachromone A
Catalog No.:BCN9403
CAS No.:1606149-62-5
- Minisecolide C
Catalog No.:BCN9416
CAS No.:1967030-77-8
- 2,6-Dihydroxyxanthone
Catalog No.:BCN9417
CAS No.:838-11-9
- Dihydromikanolide
Catalog No.:BCN9418
CAS No.:23758-04-5
- 4,5-Dihydropiperlonguminine
Catalog No.:BCN9419
CAS No.:23512-53-0
- Deoxymikanolide
Catalog No.:BCN9420
CAS No.:23753-57-3
- Macluraxanthone
Catalog No.:BCN9421
CAS No.:5848-14-6
- 4-Hydroxyxanthone
Catalog No.:BCN9422
CAS No.:14686-63-6
- 3-(Hydroxyacetyl)indole
Catalog No.:BCN9423
CAS No.:2400-51-3
- Minisecolide D
Catalog No.:BCN9424
CAS No.:1967030-78-9
- Lipodeoxyaconitine
Catalog No.:BCN9425
CAS No.:244190-83-8
- Lipoaconitine
Catalog No.:BCN9426
CAS No.:81941-14-2
- 3-epi-Dihydroscandenolide
Catalog No.:BCN9427
CAS No.:1137951-08-6
The Anti-inflammatory Activities of Two Major Withanolides from Physalis minima Via Acting on NF-kappaB, STAT3, and HO-1 in LPS-Stimulated RAW264.7 Cells.[Pubmed:27913954]
Inflammation. 2017 Apr;40(2):401-413.
Physalis minima has been traditionally used as a folk herbal medicine in China for the treatment of many inflammatory diseases. However, little is known about its anti-inflammatory constituents and associated molecular mechanisms. In our study, Withaphysalin A (WA) and 2, 3-dihydro-withaphysalin C (WC), two major withanolide-type compounds, were obtained from the anti-inflammatory fraction of P. minima. Both WA and WC significantly inhibited the production of nitrite oxide (NO), prostaglandin E2 (PGE2), and several pro-inflammatory cytokines, such as interleukin-1beta (IL-1beta), IL-6, and tumor necrosis factor-alpha (TNF-alpha) in lipopolysaccharide (LPS)-activated RAW264.7 macrophages. Further research indicated that they downregulated the LPS-induced expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) at the mRNA and protein levels. In addition, they also suppressed nuclear translocation of NF-kappaB p65, phosphorylation of STAT3, and upregulated HO-1 expression. Intriguingly, the activation of MAPKs was suppressed by WA but was not altered by WC. Taken together, these data provide scientific evidence for elucidating the major bioactive constituents and related molecular mechanisms for the traditional use of P. minima and suggest that WA and WC can be attractive therapeutic candidates for various inflammatory diseases.
Isolation, structures, and structure - cytotoxic activity relationships of withanolides and physalins from Physalis angulata.[Pubmed:17580910]
J Nat Prod. 2007 Jul;70(7):1146-52.
Phytochemical investigation of Physalis angulata was initiated following primary biological screening. Fractionation of CHCl3 and n-BuOH solubles of the MeOH extract from the whole plant was guided by in vitro cytotoxic activity assay using cultured HONE-1 and NUGC cells and led to the isolation of seven new withanolides, withangulatins B-H (1-7), and a new minor physalin, physalin W (8), along with 14 known compounds, including physaprun A, withaphysanolide, dihydrowithanolide E, physanolide A, Withaphysalin A, and physalins B, D, F, G, I, J, T, U, and V. New compounds (1-8) were fully characterized by a combination of spectroscopic methods (1D and 2D NMR and MS) and the relative stereochemical assignments based on NOESY correlations and analysis of coupling constants. Biological evaluation of these compounds against a panel of human cancer cell lines showed broad cytotoxic activity. Withangulatin B (1) and physalins D (10) and F (11) displayed potent cytotoxic activity against a panel of human cancer cell lines with EC50 values ranging from 0.2 to 1.6 microg/mL. Structure-activity relationship analysis indicated that withanolides and physalins with 4beta-hydroxy-2-en-1-one and 5beta,6beta-epoxy moieties are potential cytotoxic agents.
